Company UpdateNewspaper Publication
ServicesCommercial Services & SuppliesTrading & Distributors
Cravatex Ltd
Showing the latest 10 filings. Sign in to filter or browse the full history.
10 of 26 filings·Updated 13 Aug 2026
Showing 10 of 26 filings.
13 Aug 20261 filing
12 Aug 20261 filing
ResultFinancial Results
Cravatex reports Q1 FY27 consolidated revenue 3,222.45; PAT 43.81; EPS 1.70
Consolidated results
- Consolidated revenue from operations: 3,222.45; PAT: 43.81; EPS: 1.70 for quarter ended 30 Jun 2026.
- Total income: 3,662.63 for quarter ended 30 Jun 2026.
- Year ended 2025-26: revenue 15,087.40; PAT 679.67; EPS 26.30.
Notes & governance
- Board approved unaudited results for quarter ended 30 Jun 2026.
- Statutory auditors performed limited review of standalone and consolidated results.
- Group includes BB (UK) Ltd and BB Europe GmbH; results reviewed.
- Group operates only in one primary business segment.
31 Jul 20261 filing
AGM/EGMAGM
74th AGM convened via VC/OAVM with three ordinary resolutions including dividend declaration and director re-appointment
AGM Details
- Date and time: 31 July 2026, 3:30 PM IST; mode: VC/OAVM.
- Remote e-voting window: 28–30 July 2026; attendees allowed to vote at AGM.
- No qualifications in statutory auditor and secretarial auditor reports.
- AGM concluded at 4:10 PM IST; Scrutinizer appointed for e-voting.
Key Resolutions
- Adoption of standalone and consolidated financial statements for FY ended 31 March 2026; outcome: pending.
- Final dividend per equity share of 13 (130%); outcome: pending.
- Re-appointment of director retiring by rotation; outcome: pending.
- Voting results: to be announced within two working days.
Director Changes
- Director retiring by rotation stands for re-appointment as ordinary resolution.
8 Jul 20261 filing
Company UpdateCertificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Cravatex confirms dematerialisation processing and securities listing for the period
Dematerialisation status
- Processed all dematerialisation requests and confirmed to depositories; securities listed on exchanges.
- Physical certificates for dematerialisation were mutilated and cancelled after verification; depository name substituted as owner within timelines.
- Securities dematerialised have been listed on the stock exchanges where the previous securities are listed.
2 Jul 20261 filing
Company UpdateNewspaper Publication
Newspaper Notice published for Notice and E-voting details of 74th Annual General Meeting scheduled to be held on Friday, 31st July, 2026 at 3.30 p.m. IST through VC / OAVM is attached.
1 Jul 20262 filings
Company UpdateGeneral
Cravatex announces AGM date and provides Annual Report access; KYC updates for physical holders
AGM & KYC updates
- 74th AGM scheduled for 31 July 2026 at 3:30 PM IST via VC/OAVM.
- Weblink and exact navigation path to Annual Report 2025-26 provided.
- Notice issued to unregistered-email members; link to access report shared.
- KYC updates required for physical holders per SEBI circular; electronic payments only.
- KYC formats ISR-1/ISR-2/ISR-3 and SH-13/SH-14 available on MUFG site.
- Physical holders to update PAN, address with PIN, mobile, bank, and nomination.
- Electronic payments mandatory for physical folios from 1 April 2024.
- Reminder to update email addresses by 26 June 2026.
- Dematerialisation of physical securities encouraged.
OthersReg. 34 (1) Annual Report
Cravatex Limited – Annual Report 2025-26 highlights
Financial performance
- Standalone turnover Rs 710 Lakh; up from Rs 480 Lakh.
- PBT Rs 573.88 Lakh; PAT Rs 555.01 Lakh.
- EPS Rs 21.48; YoY growth positive.
- Total comprehensive income Rs 553.35 Lakh; OCI (1.66) Lakh.
- Final dividend Rs 13 per share; outflow Rs 335.94 Lakh.
- Standalone net worth Rs 2380 Lakh; equity Rs 258.42 Lakh; reserves Rs 2122 Lakh.
- Consolidated turnover Rs 16769.33 Lakh; PAT Rs 679.67 Lakh; EPS Rs 26.30.
- Consolidated cash flow: operating Rs 127 Lakh; investing Rs 329 Lakh; financing Rs -323 Lakh; net increase Rs 133 Lakh.
- Dividends paid during year Rs 323.02 Lakh.
Dividends & capital
- Final dividend for 2025-26 Rs 13 per share; subject to shareholder approval.
- Previous year final dividend Rs 12.50 per share paid.
- Shares outstanding 2,584,160; par Rs 10; total paid-up Rs 258.42 Lakh.
Capital & liquidity
- No long-term borrowings; net debt negative Rs 9,534.23 Lakh.
- Net worth Rs 11,943.62 Lakh; equity Rs 258.42 Lakh.
- Current ratio 5.62x; liquidity comfortable.
- Cash & cash equivalents Rs 7,653.74 Lakh; mutual funds Rs 1,872.13 Lakh.
Governance & leadership
- MD Rajesh Batra reappointed for 3 years (2025-06 to 2028-05).
- Executive Director & CFO Divakar Kamath reappointed for 3 years (2026-04 to 2029-03).
- Independent Director Rina Suresh Deora appointed from 20-May-2025; Pheroza Bilimoria ceased 13-Aug-2025.
Subsidiaries & consolidation
- BB UK Ltd: 100% subsidiary; turnover GBP 12.14m; PAT GBP 0.56m; interim dividend Rs 419.45 Lakh.
- BB Europe GmbH: Step-down subsidiary; PAT -0.18m; turnover not disclosed.
- Consolidated results reflect BB UK and BB Europe; 2025-26 turnover Rs 16,769.33 Lakh; PAT Rs 679.67 Lakh.
Related party transactions
- Dividend received from BB UK Ltd Rs 419.45 Lakh.
- Sourcing fee from Future Brands Ltd Rs 933.92 Lakh.
- Combined office/admin charges from Tecfin Consultancy Rs 12.00 Lakh.
- Space & amenities charges from Tecfin Rs 29.40 Lakh.
- Director sitting fees Rs 11.60 Lakh.
- KMP compensation Rs 501.56 Lakh.
Audit & compliance
- Statutory auditors GPS & Associates; Secretarial audit Hemanshu Kapadia; Annexure III included.
- No frauds; no qualifications; internal financial controls adequate and effective.
- CARO reports show no qualifications or material issues.
Risks & outlook
- West Asia conflict may impact trading/logistics; BB UK exposure discussed.
- Management maintains robust risk controls and ongoing internal audit monitoring.
19 May 20261 filing
Corp. ActionRecord Date
Cravatex Ltd - 509472 - Corporate Action - Intimation Of Record Date
Record date
- Purpose: 74th AGM and final dividend entitlement.
- Security: equity shares.
- Record date: 24 July 2026.
- Final dividend applies if approved by members at the AGM.
- Financial year ended 31 March 2026.
16 May 20261 filing
Company UpdateNewspaper Publication
Newspaper publication for audited financial results for the quarter and financial year ended 31st march, 2026 is attached.
7 May 20261 filing
Board Meeting
Cravatex Ltd - 509472 - Board Meeting Intimation for Board Meeting On 15/05/2026
Meeting Details
- Board meeting scheduled for Friday, 15 May 2026.
Key Agenda Items
- Consider audited standalone and consolidated financial results for quarter and year ended 31 March 2026.
- Consider recommendation of final dividend on equity shares for year ended 31 March 2026.
Other Notes
- No additional material items were disclosed in this chunk.
Showing 10 of 26 filings